Sign up to get free evidence-based articles, exclusive discounts, and insights from industry-leaders.
Email could not be subscribed.
Thank you for signing up!
presented by Cathleen Armato, RN, CHC
Financial: Cathleen Armato is a shareholder of Armato & Associates, LLC.
Nonfinancial: Cathleen Armato has no competing nonfinancial interests or relationships with regard to the content presented in this course.
Satisfactory completion requirements: All disciplines must complete learning assessments to be awarded credit, no minimum score required unless otherwise specified within the course.
MedBridge is committed to accessibility for all of our subscribers. If you are in need of a disability-related accommodation, please contact [email protected]. We will process requests for reasonable accommodation and will provide reasonable accommodations where appropriate, in a prompt and efficient manner.
Cathleen Armato, RN, CHC
Cathleen Armato is an experienced executive with 22 years in the home care and hospice industry. She has served in various roles during that time, including VP of operations and chief compliance officer for a nationwide healthcare provider. In 2012, Cat became a consultant. Since that time, she has assisted multiple organizations with their compliance…
Read full bioEmail could not be subscribed.
Thank you for signing up!
Thank you!
1. Initiating Opioids
This chapter examines the initiation of opioids and how/when to move to a fixed-dose schedule. Safe implementation is discussed as well as reassessment time schedules.
2. Breakthrough Pain Management
Breakthrough pain medication is typically necessary to control activity-related or end-of-dose-related pain. In this chapter, we examine best practices for using breakthrough medication and how to reassess at appropriate intervals.
3. Rotation of Opioids
There are several reasons for rotating opioids, but this is a complicated process that should be carefully managed. CDC-recommended methods will be reviewed using morphine milligram equivalents (MME). We will also review calculating new breakthrough dosing and reassessment timing.
More Courses in this Series
Email could not be subscribed.
Thank you for signing up!
Email could not be subscribed.
Thank you for signing up!
For groups of 5 or more, request a demo to learn about our solution and pricing for your organization. For other questions or support, visit our contact page.